David A. Spellman - Feb 27, 2023 Form 4 Insider Report for Akebia Therapeutics, Inc. (AKBA)

Role
SVP, CFO and Treasurer
Signature
/s/ Carolyn Rucci, attorney-in-fact for David A. Spellman
Stock symbol
AKBA
Transactions as of
Feb 27, 2023
Transactions value $
-$6,131
Form type
4
Date filed
3/1/2023, 03:05 PM
Previous filing
Feb 2, 2023
Next filing
Mar 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AKBA Common Stock Sale -$6.13K -7.54K -1.44% $0.81 517K Feb 27, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 26, 2021.